MYLUNG Consortium Part 3: Observational Study (MYLUNG)
Research payments
$6,601
Through program year 2025, $6,601 in research payments was reported against MYLUNG Consortium Part 3: Observational Study (MYLUNG), across 180 payments.
- Paid by (largest first)
- Janssen Scientific Affairs, LLC; Mirati Therapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $6,451 | 179 |
| 2023 | Research | $150 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Meshad Mobile, AL Named on 34 payments
- Tony Ho Portland, OR Named on 22 payments
- John Paschold Williamsburg, VA Named on 21 payments
- Venkat Pavan Kancharla Palm Bay, FL Named on 21 payments
- Robert Jotte Lone Tree, CO Named on 14 payments
- Jerome Goldschmidt Christiansburg, VA Named on 11 payments
- Rami Haddad Oak Lawn, IL Named on 11 payments
- Patrick Ward Cincinnati, OH Named on 10 payments
- Michael Poiesz Pensacola, FL Named on 9 payments
- David Hakimian Niles, IL Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.